Rita S. Mehta

6.0k total citations · 1 hit paper
81 papers, 4.0k citations indexed

About

Rita S. Mehta is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Cancer Research. According to data from OpenAlex, Rita S. Mehta has authored 81 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 35 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Rita S. Mehta's work include Breast Cancer Treatment Studies (25 papers), MRI in cancer diagnosis (23 papers) and HER2/EGFR in Cancer Research (15 papers). Rita S. Mehta is often cited by papers focused on Breast Cancer Treatment Studies (25 papers), MRI in cancer diagnosis (23 papers) and HER2/EGFR in Cancer Research (15 papers). Rita S. Mehta collaborates with scholars based in United States, Taiwan and South Korea. Rita S. Mehta's co-authors include Min‐Ying Su, David Hsiang, John Butler, Bruce J. Tromberg, Albert E. Cerussi, Orhan Nalcioğlu, Hon J. Yu, Jeon‐Hor Chen, Amanda Durkin and Natasha Shah and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Rita S. Mehta

79 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

2016 446 citations Rita S. Mehta et al. profile →

Peers

Countries citing papers authored by Rita S. Mehta

Since Specialization

Citations

This map shows the geographic impact of Rita S. Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita S. Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita S. Mehta more than expected).

Fields of papers citing papers by Rita S. Mehta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita S. Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita S. Mehta. The network helps show where Rita S. Mehta may publish in the future.

Co-authorship network of co-authors of Rita S. Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Rita S. Mehta. A scholar is included among the top collaborators of Rita S. Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita S. Mehta. Rita S. Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Disparities in Receipt of National Comprehensive Cancer Network Guideline-Adherent Care and Outcomes among Women with Triple-Negative Breast Cancer by Race/Ethnicity, Socioeconomic Status, and Insurance Type 2023 ·Cancers ·(unknown), Jenny Chang, Argyrios Ziogas, Rita S. Mehta, Kari J. Kansal, Jason A. Zell	6
2	Thymidine kinase activity levels in serum can identify HR+ metastatic breast cancer patients with a low risk of early progression (SWOG S0226) 2023 ·Biomarkers ·Mattias Bergqvist, (unknown), (unknown), Costanza Paoletti, William E. Barlow, Erin F. Cobain, Rita S. Mehta, Julie R. Gralow, Gabriel N. Hortobágyi, Kathy S. Albain, Lajos Pusztai, Priyanka Sharma, Andrew K. Godwin, Alastair M. Thompson, Daniel F. Hayes, James M. Rae	5
3	Automatic Detection and Segmentation of Breast Cancer on MRI Using Mask R-CNN Trained on Non–Fat-Sat Images and Tested on Fat-Sat Images 2020 ·Academic Radiology ·Yang Zhang, Si‐Wa Chan, Vivian Youngjean Park, (unknown), (unknown), Min Jung Kim, (unknown), Peter Chang, Daniel Chow, Ritesh Parajuli, Rita S. Mehta, (unknown), (unknown), Jeon‐Hor Chen, Min‐Ying Su	50
4	Benign Metastasizing Leiomyoma to the Lung and Spine: A Case Report and Literature Review 2019 ·Case Reports in Oncology ·(unknown), (unknown), Rita S. Mehta, Erin Lin, Karen Lane, Yu Cheng, Ritesh Parajuli	14
5	Somatic BRCA2 Mutation-Positive Concurrent Accessory Male Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC): Excellent Efficacy of Palbociclib, Fulvestrant and Leuprolide in Platinum-Exposed and Endocrine-Refractory BC Associated with Cyclin D1 and FGFR1 Amplification and of Carboplatin, Paclitaxel and Radiation in NSCLC 2019 ·Case Reports in Oncology ·Yu Cheng, (unknown), (unknown), Ritesh Parajuli, Rita S. Mehta	6
6	Radiation-Associated Angiosarcoma of the Breast: A Case Report and Literature Review 2018 ·Case Reports in Oncology ·Yung Lyou, (unknown), Rita S. Mehta, Thomas Lee, (unknown), Ritesh Parajuli	7
7	Background Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy 2015 ·Translational Oncology ·(unknown), Hon J. Yu, Christine Hsu, Rita S. Mehta, Philip M. Carpenter, Min‐Ying Su	46
8	Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer 2013 ·Obstetrical & Gynecological Survey ·Harry D. Bear, Gong Tang, Priya Rastogi, Charles E. Geyer, André Robidoux, James N. Atkins, Luis Báez-Díaz, Adam Brufsky, Rita S. Mehta, Louis Fehrenbacher, James A. Young, Francis M. Senecal, Rakesh Gaur, Richard G. Margolese, Paul T. Adams, Howard M. Gross, Joseph P. Costantino, Sandra M. Swain, Eleftherios P. Mamounas, (unknown)	64
9	Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI 2013 ·Magnetic Resonance Imaging ·Jeon‐Hor Chen, Hon J. Yu, Muqing Lin, Rita S. Mehta, Min‐Ying Su	30
10	Diagnostic Performance of Magnetic Resonance Imaging for Assessing Tumor Response in Patients With HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy is Associated With Molecular Biomarker Profile 2012 ·Clinical Breast Cancer ·(unknown), Jeon‐Hor Chen, Shadfar Bahri, Rita S. Mehta, Philip M. Carpenter, (unknown), Hon J. Yu, David Hsiang, Karen Lane, John Butler, Stephen A. Feig, Min‐Ying Su	31
11	Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy 2011 ·Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences ·Albert E. Cerussi, (unknown), David Hsiang, John Butler, Rita S. Mehta, Bruce J. Tromberg	87
12	The role of diatom test in aquatic dismemberment and drowning 2011 ·Journal of Forensic Medicine ·Vandana Vinayak, (unknown), Rita S. Mehta, (unknown), Anshuman Rai, Anil Kumar	1
13	Comparison of breast density measured on MR images acquired using fat‐suppressed versus nonfat‐suppressed sequences 2011 ·Medical Physics ·Daniel Chang, Jeon‐Hor Chen, Muqing Lin, Shadfar Bahri, Hon J. Yu, Rita S. Mehta, Ke Nie, David Hsiang, Orhan Nalcioğlu, Min‐Ying Su	27
14	Rational and Successful Use of Carboplatin and Albumin-Bound Paclitaxel in a Patient with Recurrent Metaplastic Carcinoma Who Presented with Multi-Organ Tumor Emboli 2009 ·Clinical Breast Cancer ·Rita S. Mehta, (unknown), J N Marshall, Philip M. Carpenter	1
15	Need for a new treatment strategy: leptomeningeal carcinomatosis from gastric cancer 2009 ·Anti-Cancer Drugs ·(unknown), Homayoon Sanati, Rita S. Mehta, Jason A. Zell	6
16	Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 T 2006 ·Magnetic Resonance Materials in Physics Biology and Medicine ·(unknown), Min‐Ying Su, Hon J. Yu, Orhan Nalcioğlu, Rita S. Mehta	73
17	An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing 2006 ·Journal of Translational Medicine ·Kehui Wang, Kevin Nishimoto, Rita S. Mehta, Edward L. Nelson	8
18	Imaging in breast cancer: Diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy 2005 ·Breast Cancer Research ·Bruce J. Tromberg, Albert E. Cerussi, Natasha Shah, (unknown), Amanda Durkin, David Hsiang, John Butler, Rita S. Mehta	204
19	Factors Associated With Success of the Extreme Drug Resistance Assay in Primary Breast Cancer Specimens 2002 ·Breast Cancer Research and Treatment ·Robert J. Ellis, Carol J. Fabian, Bruce F. Kimler, Ossama Tawfik, Matthew S. Mayo, (unknown), William R. Jewell, Carol S. Connor, (unknown), (unknown), Marilee McGinness, Rita S. Mehta, John P. Fruehauf	6
20	The Prognostic Value of Tumor Markers in Patients with Glioblastoma Multiforme: Analysis of 32 Patients and Review of the Literature 2001 ·Journal of Neuro-Oncology ·John Reavey‐Cantwell, Raymond I. Haroun, Marianna Zahurak, Richard E. Clatterbuck, R. J. Parker, Rita S. Mehta, John P. Fruehauf, Henry Brem	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact